Cargando…
P-cadherin counteracts myosin II-B function: implications in melanoma progression
BACKGROUND: Malignant transformation of melanocytes is frequently attended by a switch in cadherin expression profile as shown for E- and N-cadherin. For P-cadherin, downregulation in metastasizing melanoma has been demonstrated, and over-expression of P-cadherin in melanoma cell lines has been show...
Autores principales: | Jacobs, Koen, Van Gele, Mireille, Forsyth, Ramses, Brochez, Lieve, Vanhoecke, Barbara, De Wever, Olivier, Bracke, Marc |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949802/ https://www.ncbi.nlm.nih.gov/pubmed/20860798 http://dx.doi.org/10.1186/1476-4598-9-255 |
Ejemplares similares
-
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response
por: De Wolf, Katrien, et al.
Publicado: (2017) -
Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanoma
por: Speeckaert, Reinhart, et al.
Publicado: (2012) -
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
por: Chevolet, Ines, et al.
Publicado: (2015) -
Long non-coding RNAs in cutaneous melanoma: clinical perspectives
por: Hulstaert, Eva, et al.
Publicado: (2017) -
Substrate stiffness regulates cadherin-dependent collective migration through myosin-II contractility
por: Ng, Mei Rosa, et al.
Publicado: (2012)